chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female with allergy to latex who was vaccinated with GARDASIL. Concomitant therapy included penicillin (unspecified). 4 to 6 hours later the patient broke out in hives. The reporter was  uncertain if hives were related to the GARDASIL. The patient sought unspecified medical attention. Additional information has been requested.
Acute abdominal pain, lower rt abdomen, 4 days after all tests was believed to be inflammation of lymph nodes on intestine; tx ATB for 24 hrs;
I got Moderna 2nd dose on 02-12-21.  When I got home, I felt light headed and spent the rest of the week in bed with flu like symptoms and arm pain.  After this, I began to experience pain and pressure in chest and lung areas.  I'm still light headed. I still have the  chest and lung symptoms and have cardiology and pulmonology appointments.  Dr suggested I file a report about my symptoms.
Cellulitis to R Thigh Large Cellulitis to L Thigh Started on Bactrim & Orapred
Soon after receiving the Tetanus and Hip A shot. I Delevoped a sense of itching, Blood pressure taken 6 times. 145/111 stayed 1 hour at health dept then released.
Patient felt flush, dizzy, and heart started racing. Patient moved to cot via wheelchair-laid down with legs elevated. After 5 minutes patient sat upright and sipped water. VS-BP 98/65, HR 73, SpO2-98. At 0945 patient reported feeling better-walked out of clinic.
Pt vaccinated with DTP/OPV 6 hrs after shot pt had hyporesponsive rx child was pale & "limp" per moms report also wimpened for 4 hrs.
covid 19 positive; covid 19 positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 5-year-old male patient received BNT162b2 (BNT162B2), on 05Jan2022 as dose 1, single (Lot number: FK5618) and on 26Jan2022 as dose 2, single (Lot number: FL0007) at the age of 5 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 12Jul2022, outcome "recovering" and all described as "covid 19 positive". The event "covid 19 positive" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: No other vaccine in four weeks. The patient had inhaler as treatment. No follow-up attempts are possible. No further information is expected.
Vial was initally stored in refrigrator of 08-Jul-2022 and was adminstered on 10-Aug-2022; No adverse event; Patient administered vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vial was initally stored in refrigrator of 08-Jul-2022 and was adminstered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 10-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initally stored in refrigrator of 08-Jul-2022 and was adminstered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vial was initally stored in refrigrator of 08-Jul-2022 and was adminstered on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vial was initally stored in refrigrator of 08-Jul-2022 and was adminstered on 10-Aug-2022).    No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter. The vial was initially stored in the refrigerator on 08-Jul-2022. The vial did not undergo the temperature excursion.
Received vaccination and was observed for 30 minutes prior to leaving site.  Patient returned to vaccination clinic with complaints of facial swelling, tightness in throat, splotchy skin, swelling of L wrist and fingers; hands "wrinkly" in appearance.  Symptoms lasting 30-40  minutes and had began to calm down prior to return.   Assessment: BP: 178/88, P: 73; O2 Sat: 99 %.  Lungs CTA.   Epi available-not given.   EMS deployed to the scene.  States improvement in facial swelling and itching.  3:15 EMS arrived; BP: 188/102..  Patient counseled and transport to hospital offered and declined by patient.   Patient acknowledged  risks of stroke, MI, and delayed anaphylaxis.
soreness at injection site; Injection site red rash; Redness at injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In AUG-2023, the patient received the 1st dose of Shingrix (intramuscular, left arm). In AUG-2023, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness at injection site), injection site rash (Verbatim: Injection site red rash) and injection site erythema (Verbatim: Redness at injection site). The outcome of the injection site pain, injection site rash and injection site erythema were unknown.   It was unknown if the reporter considered the injection site pain, injection site rash and injection site erythema to be related to Shingrix.     It was unknown if the company considered the injection site pain, injection site rash and injection site erythema to be related to Shingrix.   Additional Information: GSK Receipt Date: 16-AUG-2023 The patient reported he administered 1st dose of Shingrix at a local pharmacy 2 days ago (14 August 2023). He reported red rash and soreness at the injection site. Lot and expiration date details of the vaccine were unknown. The reporter did not consented to follow up with healthcare professional.
Patient went to clinic for pediatric Pfizer booster. Patient received Pfizer Comirnaty (adult dose).
Body Aches; Chills; Fever; Headache; Fatigue; Flu like symptoms; A spontaneous report was received from a consumer concerning a patient of age 31 years old, male who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced multiple events of flu like symptoms, body aches, chills, fever, headache and fatigue.  The patient's medical history was not provided. Concomitant medications reported included gliclazide and esomeprazole sodium for unknown indication.   On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273.   On 30 Dec 2020, the patient developed flu like symptoms and experienced body aches, chills, fever, headache and fatigue. The treatment for the events included, Tylenol.    Action taken with mRNA-1273 in response to the events was not reported.   The outcome for the events flu like symptoms, body aches, chills, fever, headache and fatigue were unknown.; Reporter's Comments: This case concerns a 31 year old male patient who received their first of two planned doses of mRNA-1273 (Lot 025L2014), and who experienced the non-serious listed events of chills, fever, headache, and fatigue, and the non-serious unlisted events of flu-like symptoms and body aches.  Based on the current available information and temporal association between the use of the product and the onset of events on the day after vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
After the first 10 minutes I felt dizzy, I got a cold sweat and them my throat become tight -I was feeling like having two hands on my neck squeezing it like they want to struggle me), I couldn't swallow well and I had problem with my breathing. After 30 minutes I was feeling my tongue becoming bigger.  The same day I started having problems with my heart. My pulses are super high even when I am laying on bed and I have a chest pain. My cardiologist Dr. at Hospital has ordered a lot of tests but he still doesn't know what the heart muscle reacts like that. I have put Holter, I have done stress treatmill, many blood tests while I have scheduled the table exam and an exam to test my lungs because after the vaccine I have a big difficulty in breathing.
pt c/o "fuzziness".  Slumped in chair post immz given pupil dilated.  Assisted to cot when appropriate.  Applied cool rag.  Given snack & juice when recovered.  Total time 10 minutes.
Arm soreness at sight of injection ans involving shoulder. Extreme pain with arm movement.  Difficult to move arm especially lifting arm over head.
PATIENT REFERRED STRONG HEADACHE. PATIENT WAS TRANSFERRED TO HOSPITAL TO BE OBSERVED
This spontaneous report as received from a pharmacist, who was also the patient's mother, refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 11-JUL-2016, the patient was vaccinated orally with the first dose of ROTATEQ oral liquid (dose, lot# and expiry date were not reported). Then, on 21-JUL-2016, the patient was inadvertently vaccinated orally with the second dose of ROTATEQ oral liquid (dose, lot# and expiry date were not reported) by an unspecified healthcare provider. There were no concomitant therapies reported. No adverse effect were reported. There was no product quality complaint involved. Additional information has been requested.
Severe chills; Body aches; Musculoskeletal issues in upper back; Dose 1: 08Apr2021; Dose 2: 22Apr2021; Have not felt like myself since dose 2; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included gastrointestinal ischemia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant therapies were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 08Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, the patient had not felt like herself since dose 2. On 23Apr2021 at 22:45 the patient experienced severe chills, body aches and musculoskeletal issues in upper back. The patient also reported that chiropractor also informed her that he has seen several patients develop strange musculoskeletal issues following dose 1 or 2 of the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of not felt like herself since dose 2, severe chills, body aches and musculoskeletal issues in upper back and included treatment under chiropractor's care and taking anti-inflammatory medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events not felt like herself since dose 2, severe chills, body aches and musculoskeletal issues in upper back were recovered with sequelae.  No follow-up attempts are needed. No further information is expected.
Persistent arm pain/swelling at injection site, faded after ~4 days.  Replaced by heat, swelling and redness as well as itching in a roughly oval shape about 1.5x2.5 inches big. Oval not centered around injection site but slightly down and to the left (closer to the torso).   Itching started about 6-7 days after vaccine administration.
100F Fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (100F Fever) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 17-Jun-2021, the patient experienced PYREXIA (100F Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of UNK dosage form. At the time of the report, PYREXIA (100F Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature (36.1-37.2 degree Celsius): 37.778 degree Celsius High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This is the 9th day after being injected.  My injection site is still swollen, tender, warm, red, hard lump.
Patient noticed body aches, as well as redness & swelling at injection site, at 2:30 PM. She woke up at 4 A.M. On 9-25 with a fever of 103 degrees, & called an Emergency dept. She was told not to come in, but to take Ibuprofen to control her fever. Missed work on 9/27, but is in today (temp 99.2). Will see doctor today.
pt recv vax 16MAY96 & 1JUN96 pt devel full-blown chickenpox;
This spontaneous report was received from a currently 64 year old female patient, who was also a veterinarian reporting on herself. The patient's concurrent conditions included high blood pressure and heart problems. The patient's known allergies included sulfa allergy. Furthermore, the patient's medical history included brain surgery prior vaccination with PNEUMOVAX 23. The patient's concomitant therapies included an unspecified blood pressure medicine, ADVAIR, influenza virus vaccine and DECADRON. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23, intramuscularly (anatomical route of vaccination, lot number and expiration date were not provided) for prophylaxis. On an unknown date, after vaccination with PNEUMOVAX 23, the patient experienced a panic attack, trouble breathing and low oxygen levels (units not provided). Due to it, on an unknown date, the patient was hospitalized for 6 days, in which she received respiration therapy. Computed tomography (CT) scan, x rays and blood work were performed, however results were not provided. The patient also reported, she was not supposed to receive vaccines while on therapy with DECADRON. Furthermore, no product quality issue was involved. At the time of the report, the outcome of panic attack, oxygen saturation decreased and dyspnoea was reported as not recovered. Additionally, the reporter did not provide for a causality between the adverse events and vaccination with PNEUMOVAX 23. Additional information has been requested.
Raised hives/whelps within the first 2 hours, low grade fever, severe diarrhea causing sever rash. Given 2.5ml of benadryl morning and night but the symptoms continued for at over 72 hours.
12 hrs after vaccine I was awaken by stabbing pain in my right thigh and chest pain.  Pain lasted about 5 min, after which my muscles started rapidly twitching all over body. Muscles are twitching every few seconds, I am having multiple muscle cramps at random times, sharp intermittent pain all over body.  I started having frequent tremors in my hands, muscles feel strained and it is difficult to walk or perform on the piano (my job).  2 days ago I started experiencing constant pins and needles all over my body.  My pulse is in the 80s (normally in the 60s), I feel frequent heart palpitations.
Other meds; potassium chloride, VitD3, super B complex, Cal-mag-zinc. Increased neuropathy with increased pain, stiffness, myalgia, arthralgia, prickly skin feeling all over, sensitive. Criteria for reporting: states saw Dr. 1-18-21, prescribed steroids. Took prescribed pain meds and prevented her daily activity; Grade 3 for pain and fatigue, myalgia, arthralgia.
I have always gotten arm pain with any vaccine I have taken and any dose. However, this time, the pain is not going away. It goes from the shoulder to my elbow, sometimes it goes down to my wrist. It has been over a week and the pain is not stopping, and so I did a video call with clinic and they told me to just keep taking tylenol and wait it out.
Severe headache.  Ten days after vaccine.  First headache lasted about 1 1/2 hours, waking me from sleep in the morning.    Second one lasted about 1 1/2 hours, occurring in the late afternoon.  I took 2 Tylenol to alleviate the symptoms the second event.
had the shot /I got the shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shot years ago and this year he/she got the shingles. The patient stated need the new shots he/she could not had the shingles shot till March. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 15-MAY-2019,  the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R024906 with expiration date 30-AUG-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
Arm was tender and started the same day in evening , Blinding pounding head arch 12/31/2020.  Message her Dr. and asked if she could take the headache  Napicine Sodium 1 550 mg.  Day 8 arm swelled up at injection site, hot, and itchy and slight fever,  body was warm , day 9 went to talk with nurse and was given ice pack . Following day was not able to lift to extend to work .  Recommended to take an allergy pill, she left half day of work and she rested and  illness subside.
Information has been received from a pharmacist concerning a patient who on approximately 08-NOV-2010 ("in the past week") was subcutaneously vaccinated with a dose of PNEUMOVAX 23 (lot # not reported). On approximately 08-NOV-2010 ("in the past week") the patient experienced a case of cellulitis at the injection site of a subcutaneous vaccination with PNEUMOVAX 23. Unspecified medical attention had been sought. At the time of reporting, the outcome of the patient was unknown. Additional information has been requested.
(Privacy) living in (Privacy) (sorry for the typos mistakes !).   Apparition of a chronic disease (ulcerative colitis).  After the second  shot lot # EW0164  Pfizer April 11 \2021\ : blood in my stool (apparition  - did not think it was linked)  I was thinking the blood was due to hémorroïdes, and so I did not see a doctor for this.   After my 3nd dose : Nov 13 \2021\, Pfizer  #FH8028 :  A lot of pain in the stomach end of november. Consultation of a doctor, colonoscopy done jan 7 2022 : ulcerative colitis highlighted.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 26-AUG-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot # J001694, expiration date 08-MAY-2014, dose, frequency, route and indication not reported). The vaccine was stored improperly at temperatures up to 21F from 01-JUL-2013 to 08-OCT-2013. On 08-OCT-2013, the vaccine was discarded. No adverse effects were reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.